Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma.
Hwu WJ, Krown SE, Menell JH, Panageas KS, Merrell J, Lamb LA, Williams LJ, Quinn CJ, Foster T, Chapman PB, Livingston PO, Wolchok JD, Houghton AN.
Hwu WJ, et al. Among authors: livingston po.
J Clin Oncol. 2003 Sep 1;21(17):3351-6. doi: 10.1200/JCO.2003.02.061.
J Clin Oncol. 2003.
PMID: 12947072
Clinical Trial.